Zhou X[au] - Search Results

Year	Number of Results
1979	4
1980	4
1981	6
1982	13
1983	18
1984	15
1985	16
1986	24
1987	37
1988	41
1989	33
1990	53
1991	48
1992	57
1993	81
1994	86
1995	83
1996	130
1997	131
1998	155
1999	166
2000	226
2001	229
2002	272
2003	326
2004	428
2005	557
2006	617
2007	702
2008	807
2009	895
2010	1094
2011	1329
2012	1545
2013	1932
2014	2160
2015	2570
2016	2565
2017	2972
2018	3372
2019	3868
2020	4641
2021	5149
2022	4384
2023	5

1

Pembrolizumab plus Chemotherapy in Advanced Triple-Negative Breast Cancer.

Cortes J, Rugo HS, Cescon DW, Im SA, Yusof MM, Gallardo C, Lipatov O, Barrios CH, Perez-Garcia J, Iwata H, Masuda N, Torregroza Otero M, Gokmen E, Loi S, Guo Z, Zhou X, Karantza V, Pan W, Schmid P; KEYNOTE-355 Investigators. Cortes J, et al. Among authors: zhou x. N Engl J Med. 2022 Jul 21;387(3):217-226. doi: 10.1056/NEJMoa2202809. N Engl J Med. 2022. PMID: 35857659 Clinical Trial.

2

Directed evolution of adeno-associated virus for efficient gene delivery to microglia.

Lin R, Zhou Y, Yan T, Wang R, Li H, Wu Z, Zhang X, Zhou X, Zhao F, Zhang L, Li Y, Luo M. Lin R, et al. Among authors: zhou x. Nat Methods. 2022 Aug;19(8):976-985. doi: 10.1038/s41592-022-01547-7. Epub 2022 Jul 25. Nat Methods. 2022. PMID: 35879607

3

Retraction Note: LncGPR107 drives the self-renewal of liver tumor initiating cells and liver tumorigenesis through GPR107-dependent manner.

Huang G, Jiang H, Lin Y, Xia W, Luo Y, Wu Y, Cai W, Zhou X, Jiang X. Huang G, et al. Among authors: zhou x. J Exp Clin Cancer Res. 2022 Jul 25;41(1):231. doi: 10.1186/s13046-022-02414-1. J Exp Clin Cancer Res. 2022. PMID: 35879793 Free PMC article. No abstract available.

4

Macrophage phenotype-switching in cancer.

Zhang J, Zhou X, Hao H. Zhang J, et al. Among authors: zhou x. Eur J Pharmacol. 2022 Sep 15;931:175229. doi: 10.1016/j.ejphar.2022.175229. Epub 2022 Aug 21. Eur J Pharmacol. 2022. PMID: 36002039 Review.

5

When AIE meets enzymes.

Feng G, Liao S, Liu Y, Zhang H, Luo X, Zhou X, Fang J. Feng G, et al. Among authors: zhou x. Analyst. 2022 Sep 12;147(18):3958-3973. doi: 10.1039/d2an00679k. Analyst. 2022. PMID: 35929552 Review.

6

GLI1-rearranged mesenchymal tumor in the ovary.

Hui L, Bai Q, Yang W, Xiaoyu T, Yao Q, Zhou X, Rui B. Hui L, et al. Among authors: zhou x. Histopathology. 2022 Aug 29. doi: 10.1111/his.14785. Online ahead of print. Histopathology. 2022. PMID: 36053785 No abstract available.

7

Role of pyroptosis in inflammation and cancer.

Wei X, Xie F, Zhou X, Wu Y, Yan H, Liu T, Huang J, Wang F, Zhou F, Zhang L. Wei X, et al. Among authors: zhou x. Cell Mol Immunol. 2022 Sep;19(9):971-992. doi: 10.1038/s41423-022-00905-x. Epub 2022 Aug 15. Cell Mol Immunol. 2022. PMID: 35970871 Free PMC article. Review.

8

Electrically switched underwater capillary adhesion.

Zheng H, Li J, Zhou Y, Zhang C, Xu W, Deng Y, Li J, Feng S, Yi Z, Zhou X, Ji X, Shi P, Wang Z. Zheng H, et al. Among authors: zhou x. Nat Commun. 2022 Aug 6;13(1):4584. doi: 10.1038/s41467-022-32257-5. Nat Commun. 2022. PMID: 35933460 Free PMC article.

9

ty-5 Confers Broad-Spectrum Resistance to Geminiviruses.

Ren Y, Tao X, Li D, Yang X, Zhou X. Ren Y, et al. Among authors: zhou x. Viruses. 2022 Aug 17;14(8):1804. doi: 10.3390/v14081804. Viruses. 2022. PMID: 36016426 Free PMC article.

10

Posttranslational control of lipogenesis in the tumor microenvironment.

Zhu Y, Lin X, Zhou X, Prochownik EV, Wang F, Li Y. Zhu Y, et al. Among authors: zhou x. J Hematol Oncol. 2022 Aug 29;15(1):120. doi: 10.1186/s13045-022-01340-1. J Hematol Oncol. 2022. PMID: 36038892 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results